ConductScience.org, home

Comparison · NCT02551094-7c843644

Colchicine vs Colchicine Placebo: First Event of Cardiovascular Death, Resuscitated Cardiac Arrest, Acute Myocardial Infarction, Stroke, or Urgent Hospitalization for Angina Requiring Coronary Revascularization

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Colchicine vs Colchicine Placebo: First Event of Cardiovascular Death, Resuscitated Cardiac Arrest, Acute Myocardial Infarction, Stroke, or Urgent Hospitalization for Angina Requiring Coronary Revascularization. Trial comparisons, record NCT02551094-7c843644. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02551094-7c843644

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.05540.04690.0653wilson
Risk in group 20.07150.06180.0825wilson
Risk difference, group 1 minus group 2-0.0161-0.03-0.00221newcombe hybrid score
Risk ratio, group 1 over group 20.7750.6210.966log
Odds ratio, group 1 over group 20.7620.6020.964log
Number needed to treat, for one fewer participant with the outcome on Colchicine than on Colchicine Placebo62.133.3453from the risk difference interval

Groups2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Colchicine0.5 mg tablet of colchicine taken once a day~colchicine: 0.5 mg tablet taken once a day1312,366OG001
Group 2Colchicine Placebo0.5 mg tablet of placebo taken once a day~colchicine placebo: sugar pill manufactured to mimic colchicine 0.5 mg tablet1702,379OG000

Outcome

Type
PRIMARY
Title
First Event of Cardiovascular Death, Resuscitated Cardiac Arrest, Acute Myocardial Infarction, Stroke, or Urgent Hospitalization for Angina Requiring Coronary Revascularization
Description
The descriptive statistics are the number of participants having at least one of the composites of the primary endpoint.
Time frame
From randomization to occurence of first event, assessed up to 3.5 years
Population

Source ClinicalTrials.gov

Trial

Title
Colchicine Cardiovascular Outcomes Trial (COLCOT)
NCT number
NCT02551094
Phases
PHASE3
Conditions
Coronary Artery Disease, Myocardial Infarction
Interventions
colchicine, colchicine placebo
Lead sponsor
Montreal Heart Institute
Results first posted
2020-10-19

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02551094-7c843644